Scientists hunt for clues to drug resistance in tough colorectal cancer
NCT ID NCT07617610
First seen Jun 25, 2026 · Last updated Jul 17, 2026 · Updated 3 times
Summary
This study looks at why a specific type of advanced colorectal cancer (with a BRAF V600E mutation) becomes resistant to standard targeted therapy. Researchers will collect tumor tissue, blood, and stool samples from 30 patients before treatment and when the disease progresses. They will also grow mini-tumors in the lab to test new ways to overcome resistance. The goal is to gather knowledge that could lead to more effective treatments in the future.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Longitudinal translational sampling (tumor tissue, blood, stool) and patient-derived organoids
- What this could lead to
- If successful, this could reveal why current treatments stop working and point toward new drug combinations to overcome resistance.
- What could go wrong
- This is an early-stage observational study with only 30 participants, so findings may not apply to all patients. It does not test a new treatment directly.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRAF V600E MUTATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Bürgerspital Solothurn
RECRUITINGSolothurn, 4500, Switzerland
-
HFR Freiburg - Kantonsspital
RECRUITINGVillars-sur-Glâne, 1752, Switzerland
-
HOCH Health Ostschweiz - Kantonsspital St. Gallen
RECRUITINGSankt Gallen, 9007, Switzerland
-
Inselspital Bern
RECRUITINGBern, 3010, Switzerland
-
Kantonsspital Aarau
RECRUITINGAarau, CH-5000, Switzerland
-
Kantonsspital Baden
RECRUITINGBaden, 5404, Switzerland
-
Kantonsspital Graubünden
RECRUITINGChur, 7000, Switzerland
-
Kantonsspital Winterthur
RECRUITINGWinterthur, 8004, Switzerland
-
Luzerner Kantonsspital
RECRUITINGLucerne, 6004, Switzerland
-
Spitalzentrum Biel - MEDIN La Tour
RECRUITINGBiel, 2502, Switzerland
-
St. Claraspital
RECRUITINGBasel, 4058, Switzerland
-
Universitaetsspital Basel
RECRUITINGBasel, CH-4031, Switzerland
-
Universitätsspital Zürich USZ
RECRUITINGZurich, 8091, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can delivering cancer drug directly to the liver shrink tumors?
- Blood biomarkers could replace invasive biopsies for colorectal cancer monitoring
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Can a Two-Drug combo outsmart resistant colorectal cancer?
- Can a pill boost the immune system to fight Hard-to-Treat cancers?
- Can a Triple-Drug rechallenge tame colorectal cancer?